Tuesday, August 18, 2020

NVAX Begins Vaccine Trial In S.Africa, PSTX Slapped With Clinical Hold, UTHR To Face FDA In Apr.

Today's Daily Dose brings you news about Applied Therapeutics' ACTION-Galactosemia Kids trial being placed on partial hold by the FDA, Novavax initiating its COVID-19 vaccine trial in South Africa, Sanofi acquiring Principia Biopharma for $100 per share in cash, and FDA slapping a clinical hold on Poseida's prostate cancer trial after a patient's death, among others.

from RTT - Biotech https://ift.tt/313rZFI
via IFTTT

No comments:

Post a Comment